Key Documents
Beverly S. Mitchell, M.D.
Academic Appointments
- Professor, Medicine - Oncology
- Professor (By courtesy), Chemical and Systems Biology
- Member, Cancer Center
Contact Information
-
Clinical Offices
Stanford Comprehensive Cancer Center 800 Welch Rd 2nd Fl MC5796 Stanford, CA 94305-5796 Tel Work (650) 725-9621 Fax (650) 736-0607
-
Academic Offices
Personal Information Email Tel (650) 725-9621Administrative Contact Natalie Huen Administrative Assistant Email Tel Work 650.736.7716Not for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Cancer > Hematology
- Cancer > Hematology > Hematologic Malignancies
- Cancer > Lymphoma
- Hematology
Administrative Appointments
- Director, Stanford Cancer Center (2008 - present)
- Deputy Director, Stanford Cancer Center (2005 - 2008)
Honors and Awards
- President, American Society of Hematology (2001)
- Member, American Society for Clinical Investigation (to present)
- Member, Association of American Professors (1991)
- Stohlman Award, Leukemia Society of America (1988)
- National Academy of Sciences, Institute of Medicine (Inducted 2001)
Professional Education
| Board Certification: | Hematology, American Board of Internal Medicine (1978) |
| Fellowship: | University Hospital Zurich, Switzerland (1973) |
| Fellowship: | University of Michigan Hospital, MI (1977) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1973) |
| Residency: | University of Washington, WA (1973) |
Scientific Focus
Research Interests
Beverly S. Mitchell, MD, is the Director of the Stanford Cancer Center, and is the George E. Becker Professor of Medicine at Stanford University. Before joining the Stanford faculty, Dr. Mitchell lead the Molecular Therapeutics Program at UNC Chapel Hill's Lineberger Comprehensive Cancer Center, where she also served as Associate Director for Translational Research and Chief of the Division of Hematology/Oncology.
Dr. Mitchell received a bachelors degree in biochemistry from Smith College in Massachusetts and received her MD from Harvard Medical School. She completed her medical training as Chief Resident at the University of Washington. After completing a research fellowship at the Metabolic Laboratory at the University of Zurich in Switzerland she was awarded a Hematology Fellowship at the University of Michigan. Dr. Mitchell was a faculty member in the Departments of Medicine and Pharmacology at the University of Michigan for 16 years before moving to UNC.
Bev Mitchell has authored over 130 peer-reviewed articles. She served as President of the American Society of Hematology (ASH) and was Chair of the Medical and Scientific Affairs Committee and Vice Chair for Medical and Scientific Affairs of the Leukemia and Lymphoma Society of America.
Dr. Mitchell's research relates to the development of new therapies for hematologic malignancies. She has a long-standing interest in IMPDH as a therapeutic target and has published extensively on the regulation of this enzyme and the potential role of inhibitors in the treatment of leukemia in preclinical and clinical investigations.
Clinical Trials
Publications
- Regulation of the interaction of inosine monophosphate dehydrogenase with mycophenolic Acid by GTP. J Biol Chem. 2006; (1): 206-12
- The 5'-nucleotidases as regulators of nucleotide and drug metabolism. Pharmacol Ther. 2005; (1): 1-30
- Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies. J Clin Oncol. 2005; (15): 3396-403
- Synergy between imatinib and mycophenolic acid in inducing apoptosis in cell lines expressing Bcr-Abl. Blood. 2005; (8): 3270-7
- Role of estrogen receptor in the regulation of ecto-5'-nucleotidase and adenosine in breast cancer. Clin Cancer Res. 2004; (2): 708-17
Help